SMMT — Summit Therapeutics Share News
0.000.00%
Last trade - 00:00- $10.87bn
- $10.28bn
Brief: Summit Therapeutics reports inducement grants under Nasdaq listing rule 5635(C)(4)
Summit Therapeutics falls on wider Q4 loss, deal expectations from investors
U.S. STOCKS ON THE MOVE-Starbucks, Bristol Myers Squibb, Home Depot
U.S. STOCKS ON THE MOVE-BioMarin, Azul, Sun Communities
U.S. STOCKS ON THE MOVE- Twilio, Bath & Body Works, Wingstop
U.S. STOCKS ON THE MOVE-Nike, Domino's Pizza, Apple
Brief: Summit Therapeutics Collaborates With Pfizer To Evaluate Ivonescimab Trial
Summit Therapeutics rises on clinical trial collaboration with Pfizer
Brief: Summit Therapeutics Q4 Net Income USD -61.2 Million
Summit Therapeutics Inc expected to post a loss of 8 cents a share - Earnings Preview
U.S. STOCKS ON THE MOVE-Axon, AngioDynamics, Phreesia
Summit Therapeutics rises after Truist starts coverage with 'buy' rating
Summit Therapeutics Inc reports results for the quarter ended in September 30 - Earnings Summary
Brief: Summit Therapeutics Q3 Net Income USD -56.3 Million
Summit Therapeutics Inc expected to post a loss of 7 cents a share - Earnings Preview
Brief: Summit Therapeutics Announces Completion Of Enrollment In Phase III HARMONI Trial In 2L+ EGFRM NSCLC
Brief: Summit Therapeutics Inc Files For Offering Of 10.4 Million Shares Of Common Stock By Selling Stockholder - SEC Filing
U.S. STOCKS ON THE MOVE-Unity Software, Viking Holdings, Adobe
U.S. STOCKS ON THE MOVE-Gold miners, silver miners, Warner Bros Discovery